United Therapeutics CEO Sells $5 Million of Shares. What Does This Mean for Investors?

United Therapeutics CEO Sells $5 Million of Shares. What Does This Mean for Investors?

Key Points9,500 shares were disposed of for ~$5.0 million based on a weighted average execution price of $530.42 on July 27, 2026.The transaction represents a 1% reduction in total equity holdings, leaving the insider with ~669,000 shares across direct and indirect accounts.Activity was conducted through various family trusts and a spouse's account following the exercise of 9,500 options at $135.42.The sale was executed under a Rule 10b5-1 tradi…